Perrigo Sees ProAir Advantage After Late February Launch
Launch With Catalent Was 15 Years In The Making
The culmination of 15 years of work saw Perrigo introduce the first generic version of Teva’s ProAir in late February. Preliminary results released by the company for its financial first quarter reveal the launch has provided Perrigo with the expected boost in sales.
